We chose the ovarian cancer cell line OVCAR-3, where prior work has established via in vitro and in vivo genetic knockdown experiments that growth of OVCAR-3 cells is driven by cyclin E1 overexpression and dependent on CDK2. The gene discussed is CDK2; the disease is ovarian carcinoma.